About
Omnidermal Biomedics is an Italian startup founded in 2017, emerging from the Politecnico di Torino. The company specializes in developing medical devices that integrate artificial intelligence to assist healthcare professionals in dermatology and wound care. Their flagship product, WoundViewer, is the first AI-powered device designed to automatically analyze and quantify skin ulcers. It provides essential clinical parameters, significantly reducing the time needed for wound evaluation from 20 minutes to just 2 minutes. The company targets healthcare professionals, including physicians and nurses, aiming to enhance diagnostic accuracy and treatment efficiency. Omnidermal Biomedics has received multiple funding awards for its innovations, including support for developing medical devices related to COVID-19. With a leadership team experienced in biomedical engineering and AI, the company operates primarily in Italy and serves markets in the GCC and SAARC regions, focusing on improving clinical outcomes in dermatology and wound management.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2017
Location
Corso Castelfidardo, Turin, Piedmont, Italy, 10129